These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 10523851)
1. gamma-heregulin is the product of a chromosomal translocation fusing the DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell line. Wang XZ; Jolicoeur EM; Conte N; Chaffanet M; Zhang Y; Mozziconacci MJ; Feiner H; Birnbaum D; Pébusque MJ; Ron D Oncogene; 1999 Oct; 18(41):5718-21. PubMed ID: 10523851 [TBL] [Abstract][Full Text] [Related]
2. Gamma-heregulin: a fusion gene of DOC-4 and neuregulin-1 derived from a chromosome translocation. Liu X; Baker E; Eyre HJ; Sutherland GR; Zhou M Oncogene; 1999 Nov; 18(50):7110-4. PubMed ID: 10597312 [TBL] [Abstract][Full Text] [Related]
3. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175. Schaefer G; Fitzpatrick VD; Sliwkowski MX Oncogene; 1997 Sep; 15(12):1385-94. PubMed ID: 9333014 [TBL] [Abstract][Full Text] [Related]
4. A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene. Adélaïde J; Huang HE; Murati A; Alsop AE; Orsetti B; Mozziconacci MJ; Popovici C; Ginestier C; Letessier A; Basset C; Courtay-Cahen C; Jacquemier J; Theillet C; Birnbaum D; Edwards PA; Chaffanet M Genes Chromosomes Cancer; 2003 Aug; 37(4):333-45. PubMed ID: 12800145 [TBL] [Abstract][Full Text] [Related]
5. Translocation and coamplification of loci from chromosome arms 8p and 11q in the MDA-MB-175 mammary carcinoma cell line. Adélaïde J; Chaffanet M; Mozziconacci MJ; Popovici C; Conte N; Fernandez F; Sobol H; Jacquemier J; Pébusque M; Ron D; Lafage-Pochitaloff M; Birnbaum D Int J Oncol; 2000 Apr; 16(4):683-8. PubMed ID: 10717235 [TBL] [Abstract][Full Text] [Related]
6. Gamma-heregulin has no biological significance in primary breast cancer. Sánchez-Valdivieso EA; Cruz JJ; Salazar R; del Mar Abad M; Gómez-Alonso A; Gómez A; González-Sarmiento R Br J Cancer; 2002 Apr; 86(8):1362-3. PubMed ID: 11953899 [No Abstract] [Full Text] [Related]
7. NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis. Prentice LM; Shadeo A; Lestou VS; Miller MA; deLeeuw RJ; Makretsov N; Turbin D; Brown LA; Macpherson N; Yorida E; Cheang MC; Bentley J; Chia S; Nielsen TO; Gilks CB; Lam W; Huntsman DG Oncogene; 2005 Nov; 24(49):7281-9. PubMed ID: 16027731 [TBL] [Abstract][Full Text] [Related]
8. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage. Menendez JA; Mehmi I; Lupu R Int J Oncol; 2005 Mar; 26(3):649-59. PubMed ID: 15703820 [TBL] [Abstract][Full Text] [Related]
9. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer. Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525 [TBL] [Abstract][Full Text] [Related]
10. The oncogene heregulin induces apoptosis in breast epithelial cells and tumors. Weinstein EJ; Grimm S; Leder P Oncogene; 1998 Oct; 17(16):2107-13. PubMed ID: 9798682 [TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
12. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification. Ram TG; Schelling ME; Hosick HL Cell Growth Differ; 2000 Mar; 11(3):173-83. PubMed ID: 10768865 [TBL] [Abstract][Full Text] [Related]
13. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma. Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049 [TBL] [Abstract][Full Text] [Related]
14. NRG1 fusions in breast cancer. Howarth KD; Mirza T; Cooke SL; Chin SF; Pole JC; Turro E; Eldridge MD; Garcia RM; Rueda OM; Boursnell C; Abraham JE; Caldas C; Edwards PAW Breast Cancer Res; 2021 Jan; 23(1):3. PubMed ID: 33413557 [TBL] [Abstract][Full Text] [Related]
15. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells. Kang H; Mansel RE; Jiang WG Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737 [TBL] [Abstract][Full Text] [Related]
16. Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors. Schmitt M; Walker MP; Richards RG; Bocchinfuso WP; Fukuda T; Medina D; Kittrell FS; Korach KS; DiAugustine RP Mol Carcinog; 2006 Jul; 45(7):490-505. PubMed ID: 16482517 [TBL] [Abstract][Full Text] [Related]
17. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines. Liu L; Gudas LJ J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002 [TBL] [Abstract][Full Text] [Related]
18. Isolation of a heregulin-like growth factor secreted by estrogen receptor-negative MDA-MB-231 human breast cancer cells that stimulates estrogen receptor-positive cells. Küng W; David F; Langen H; Weyer KA; Schlaeger EJ; Lahm HW; Silber E; Mueller H; Eppenberger U Biochem Biophys Res Commun; 1994 Aug; 202(3):1357-65. PubMed ID: 8060314 [TBL] [Abstract][Full Text] [Related]
19. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells. Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629 [TBL] [Abstract][Full Text] [Related]
20. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling. Pan MH; Lin CC; Lin JK; Chen WJ J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]